Quantcast

Latest Medicinal chemistry Stories

2014-01-23 12:29:16

SAN DIEGO, Jan. 23, 2014 /PRNewswire/ -- Formex, LLC ("Formex"), a leader in pharmaceutical formulation and clinical trial manufacturing, announced today its sponsorship of the 3rd Drug Formulation & Bioavailability Conference to be held in Boston, MA from January 27-29, 2014. Formex CSO Blair West, Ph.D. will be joined by distinguished speakers from Merck & Co, F Hoffman-La Roche, Novartis and Boehringer-Ingelheim for a discussion entitled "Accelerating Time to Market...

2014-01-23 08:31:55

CRANBURY, N.J., Jan. 23, 2014 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential, announced today that it has received approximately $1.85 million of non-dilutive funding via the State of New Jersey's Technology Business Tax Certificate Transfer Program (the Program). This Program enables...

2014-01-22 16:26:23

NEW YORK, Jan. 22, 2014 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of AMAG Pharmaceuticals, Inc. ("AMAG Pharmaceuticals" or the "Company") (NasdaqGS: AMAG -News). The investigation focuses on whether the Company and its executives complied with federal securities laws. On January 22, 2014, shares of AMAG Pharmaceutical fell $1.36 or 6.22% during intraday trading to trade at $20.50 after the...

2014-01-22 16:25:47

SAN DIEGO and CAMBRIDGE, Mass., Jan. 22, 2014 /PRNewswire/ -- Shareholder rights law firm Robbins Arroyo LLP announces that an investor of Aegerion Pharmaceuticals, Inc. (NASDAQGS: AEGR) has filed a federal securities fraud class action complaint in the U.S. District Court, District of Massachusetts. The complaint alleges that the company and certain of its officers violated the Securities and Exchange Act of 1934 between March 15, 2012 and January 9, 2014 (the "Class Period")....

2014-01-20 23:20:20

The Firm’s attorneys are actively filing dialysis lawsuit claims on behalf of individuals who may have experienced serious heart problems following their use of GranuFlo and/or NaturaLyte. New York, NY (PRWEB) January 20, 2014 In just under a month, court documents show that nearly 30 GranuFlo lawsuits (http://www.thegranuflolawsuit.com/) have joined the federal dialysis drug litigation now underway in the U.S. District Court, District of Massachusetts, Bernstein Liebhard LLP reports....

2014-01-20 09:42:42

A new class of molecules called acyldepsipeptides — ADEPs — may provide a new way to attack bacteria that have developed resistance to antibiotics. Researchers at Brown and MIT have discovered a way to increase the potency of ADEPs by up to 1,200 times. Their findings appear in the Journal of the American Chemical Society. As concerns about bacterial resistance to antibiotics grow, researchers are racing to find new kinds of drugs to replace ones that are no longer effective. One...

2014-01-20 08:23:06

MALVERN, Pa. and CODOLET, France, Jan. 20, 2014 /PRNewswire/ -- Reaction Biology Corporation ("RBC"), a leading contract research organization providing early stage drug discovery services, announced that it has signed an agreement for Cisbio Bioassays, a cutting-edge biotechnology company in the field of products and services for human in vitro diagnostics and pharmaceutical research, to distribute its epigenetic proteins. (Logo:...

2014-01-17 08:23:23

LAKE MARY, Fla., Jan. 17, 2014 /PRNewswire/ -- VUCA Health, which has created the largest and most robust medication video library in the world to address health literacy, announced today that Liberty Software, a leading pharmacy management solution focused on innovation and customer service, will offer the MedsOnCue solution to its base of pharmacies. "The medication experience delivered by MedsOnCue is like nothing else on the market today. This is the type of innovation we like...

2014-01-14 23:29:12

CDRH has recently overhauled its Office of Compliance — what exactly has changed and what hasn’t? In this exclusive question-and-answer webinar, FDA veteran Steve Niedelman, lead quality systems and compliance consultant to the FDA & Life Sciences practice team at King & Spalding, speaks with Steve Silverman, Director of CDRH’s Office of Compliance, to help device manufacturers understand all the changes. Falls Church, VA (PRWEB) January 14, 2014 CDRH’s Office of...

2014-01-09 23:28:14

Tim Wells, former Team Leader for the FDA’s Quality System Inspection Reengineering Project, coaches devicemakers at all levels on how to understand QSIT and use its ever-changing nuances to pass their next inspection. This one-of-a-kind DVD training course features a unique insider perspective as Mr. Wells, a 24-year FDA veteran, shows how the FDA determines risk profile. Falls Church, VA (PRWEB) January 09, 2014 Secrets of QSIT-Based Medical Device Inspection Preparation **FDAnews...


Latest Medicinal chemistry Reference Libraries

European Journal of Medical Chemistry
2012-05-12 22:03:06

The European Journal of Medical Chemistry is a peer-reviewed scientific journal for medical chemistry. It is published by Elsevier. It was established in 1966 under the title Chimica Therapeutica. That name was maintained until 1973. Even after changing to its current name in 1974, the journal was still subtitled Chimica Therapeutica until 1981; from 1982 to 1986 it was subtitled Chimie Therapeutique, indicating its French origin. The Journal publishes studies on all aspects of medicinal...

More Articles (1 articles) »
Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related